Tonkin A M, Heddle W F, Tornos P
Aust N Z J Med. 1978 Dec;8(6):594-602. doi: 10.1111/j.1445-5994.1978.tb04846.x.
Twelve patients with clinical features suggesting possible intermittent high degree atrioventricular block were studied. All 12 patients had basic 1:1 atrioventricular conduction but nine had an electrocardiographic pattern of bifascicular distal conduction disease (right bundle branch block with left anterior or posterior hemiblock, or left bundle branch block). Intracardiac conduction was assessed by recording of the His bundle electrocardiogram and atrial pacing techniques, before and 20 minutes after intravenous administration of procainamide, in a dose of up to 10 mg/kg. Before procainamide administration, seven of the 12 patients had a prolonged H-V interval (greater than 55 ms). Procainamide administration lengthened the H-V interval in all 12 patients by 5--40 ms. In five patients, procainamide induced second or third degree AV block below the level of the bundle of His. It was concluded that the administration of procainamide may be a useful provocative test of distal conduction in patients with possible intermittent AV block.
对12例具有提示可能存在间歇性高度房室传导阻滞临床特征的患者进行了研究。所有12例患者均有基本的1:1房室传导,但9例有双分支远端传导疾病的心电图模式(右束支传导阻滞伴左前或左后半阻滞,或左束支传导阻滞)。在静脉注射普鲁卡因酰胺(剂量高达10mg/kg)之前和之后20分钟,通过记录希氏束心电图和心房起搏技术来评估心内传导。在给予普鲁卡因酰胺之前,12例患者中有7例H-V间期延长(大于55毫秒)。给予普鲁卡因酰胺后,所有12例患者的H-V间期延长了5-40毫秒。在5例患者中,普鲁卡因酰胺诱发了希氏束以下的二度或三度房室传导阻滞。得出的结论是,给予普鲁卡因酰胺可能是对可能存在间歇性房室传导阻滞患者进行远端传导的有用激发试验。